Skip to main content
Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
6.29
-0.14 (-2.18%)
At close: Apr 28, 2026, 4:00 PM EDT
6.29
0.00 (0.00%)
After-hours: Apr 28, 2026, 5:28 PM EDT

Aligos Therapeutics Revenue

In the year 2025, Aligos Therapeutics had annual revenue of $2.19M, down -44.59%. Aligos Therapeutics had revenue of $169.00K in the quarter ending December 31, 2025, a decrease of -73.13%.

Revenue (ttm)
$2.19M
Revenue Growth
-44.59%
P/S Ratio
18.20
Revenue / Employee
$26,659
Employees
82
Market Cap
38.92M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.19M-1.76M-44.59%
Dec 31, 20243.95M-11.58M-74.60%
Dec 31, 202315.53M1.62M11.66%
Dec 31, 202213.91M9.55M219.04%
Dec 31, 20214.36M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Atara Biotherapeutics 120.77M
Veru Inc. 16.89M
CervoMed 4.01M
Werewolf Therapeutics 1.14M
RenovoRx 1.12M
Actinium Pharmaceuticals 90.00K
INmune Bio 50.00K
Revenue Rankings

ALGS News

More News